Current Opinion in Infectious Diseases

Papers
(The TQCC of Current Opinion in Infectious Diseases is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
La Crosse virus encephalitis in children73
Skin and soft tissue infections: swab or biopsy? A diagnostic dilemma66
Strongyloidiasis-related lung involvement: too much of a bad thing64
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV56
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel54
Surgical management of cystic echinococcosis of the liver51
Prevention is all you need: generative artificial intelligence for infection prevention and healthcare epidemiology48
From diagnosis to management: current perspectives on congenital cytomegalovirus infection44
Complexities of cardiomyopathy in septic shock35
Corticosteroids for viral central nervous system infections34
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response33
Skin and soft tissue infections in the elderly33
Editorial introductions32
Tissue resident memory T cells in respiratory infections31
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management30
Typhoid fever control in the 21st century: where are we now?29
Fusarium species central nervous system infection29
Viral meningitis and encephalitis: an update28
Managing cognitive impairment in people with HIV: Erratum27
Resistant herpes simplex virus infections – who, when, and what's new?26
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?24
Tropical infectious diseases and skin manifestations: a diagnostic framework23
Malaria in pregnancy: baby steps23
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies21
Mpox in people living with HIV21
Tuberculosis molecular bacterial load assay in the management of tuberculosis21
Editorial introductions20
Tick-borne encephalitis20
Appropriate surgical management in skin and soft tissue infections20
Interventions for polyoma virus-associated hemorrhagic cystitis19
CMV antiviral stewardship in transplantation – the next frontier19
Using antibiotics wisely19
Haemophilus ducreyi in genital ulcer disease: new developments in an old disease18
Gut microbiome and its clinical implications: exploring the key players in human health18
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach18
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis18
Does climate change threaten delivery of HIV care in resource-limited settings?18
Recent advances in flavivirus encephalitis17
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV17
Diagnostic stewardship: what impacts antibiotics use?17
The plumbing problem: rising antimicrobial resistance in building water systems17
Risk stratification for selecting empiric antibiotherapy during and after COVID-1916
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections16
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles16
Update on the treatment of chronic pulmonary aspergillosis16
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential15
Childhood tuberculosis15
Editorial introductions15
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?15
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-1915
Chronic persistent Norovirus in the immune-compromised host14
The microbiome as a biomarker of anal precancerous lesions in people with HIV14
Interpreting and managing preservation fluids positive for Gram-negative bacteria14
Travellers’ diarrhoea – solidifying our knowledgebase14
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management14
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae14
Respiratory metagenomics: route to routine service14
Data science for pediatric infectious disease: utilizing COVID-19 as a model14
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities14
Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics14
Update on drug treatments for multidrug resistant tuberculosis13
Short treatment duration for community-acquired pneumonia13
Advanced neuroimaging for central nervous system infections: when, where, how, and why?13
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients13
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis13
Use of gloves: current evidence vs. current use12
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives12
An overview of risk factors, management and prevention of cochlear implant infections11
Identifying patients with difficult-to-treat acute bacterial skin infections11
Antiviral therapies for respiratory syncytial virus infection: current expectations11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans11
The disease burden of respiratory syncytial virus in Infants11
Urinary tract infections in immunocompromised patients11
Burden of influenza in the elderly: a narrative review10
Skin and soft tissue infections in solid organ transplants10
Short-course antibiotic strategies for ventilator-associated pneumonia10
Anti-inflammatory therapies for bronchiectasis10
Genetic mechanisms underlying host susceptibility to central nervous system viral infections10
Neurobrucellosis10
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities10
A new era of HIV care for age-associated multimorbidity10
Updates on the neurological manifestations of SARS-CoV-2 infection9
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances9
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens9
Chagas disease in the immunocompromised host9
The evolution of knowledge for treating Gram-negative bacterial infections9
Therapeutic agents for the treatment of human mpox9
How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach9
Immune responses and severe dengue: what have we learned?9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention9
Eravacycline: from clinical trials to its potential place in everyday therapy9
0.71650886535645